Floatz logo

Egfrt/19-28Z/Il-12 Car T-Lymphocytes

Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer CenterCell therapyPhase 1Active
C
37/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
65/ 100

Competitive context

182 Active assets in the Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
THIOGUANINE ANHYDROUS
St. Jude Children's Research Hospital
Phase 4BBB
VINCRISTINE SULFATE
Children's Oncology Group
Phase 3BB
PEGASPARGASE
Dana-Farber Cancer Institute
Phase 4BB
ASPARAGINASE
Centre Hospitalier Universitaire de Nice
Phase 4BB
Daunorubicin
PETHEMA Foundation
Phase 4BB

View all 50 →

Same molecule, other indications

Egfrt/19-28Z/Il-12 Car T-Lymphocytes is also rated in:

chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
acute lymphoblastic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →